Literature DB >> 20971059

Mitochondrial superoxide anion radicals mediate induction of apoptosis in cardiac myoblasts exposed to chronic hypoxia.

Rajitha T Kolamunne1, Michelle Clare, Helen R Griffiths.   

Abstract

Both reactive oxygen species (ROS) and ATP depletion may be significant in hypoxia-induced damage and death, either collectively or independently, with high energy requiring, metabolically active cells being the most susceptible to damage. We investigated the kinetics and effects of ROS production in cardiac myoblasts, H9C2 cells, under 2%, 10% and 21% O₂ in the presence or absence of apocynin, rotenone and carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone. H9C2 cells showed significant loss of viability within 30 min of culture at 2% oxygen which was not due to apoptosis, but was associated with an increase in protein oxidation. However, after 4 h, apoptosis induction was observed at 2% oxygen and also to a lesser extent at 10% oxygen; this was dependent on the levels of mitochondrial superoxide anion radicals determined using dihydroethidine. Hypoxia-induced ROS production and cell death could be rescued by the mitochondrial complex I inhibitor, rotenone, despite further depletion of ATP. In conclusion, a change to superoxide anion radical steady state level was not detectable after 30 min but was evident after 4 h of mild or severe hypoxia. Superoxide anion radicals from the mitochondrion and not ATP depletion is the major cause of apoptotic cell death in cardiac myoblasts under chronic, severe hypoxia. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971059     DOI: 10.1016/j.abb.2010.10.015

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Hyperoxia fully protects mitochondria of explanted livers.

Authors:  G Sgarbi; F Giannone; G A Casalena; A Baracca; M Baldassare; P Longobardi; P Caraceni; M Derenzini; G Lenaz; D Trerè; Giancarlo Solaini
Journal:  J Bioenerg Biomembr       Date:  2011-10-21       Impact factor: 2.945

2.  Hypoxia/oxidative stress alters the pharmacokinetics of CPU86017-RS through mitochondrial dysfunction and NADPH oxidase activation.

Authors:  Jie Gao; Xuan-sheng Ding; Yu-mao Zhang; De-zai Dai; Mei Liu; Can Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

Review 3.  Molecular responses to hypoxia-inducible factor 1α and beyond.

Authors:  Jason Brocato; Yana Chervona; Max Costa
Journal:  Mol Pharmacol       Date:  2014-02-25       Impact factor: 4.436

4.  H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation.

Authors:  Andrey V Kuznetsov; Sabzali Javadov; Stephan Sickinger; Sandra Frotschnig; Michael Grimm
Journal:  Biochim Biophys Acta       Date:  2014-11-18

5.  Oxidative stress under ambient and physiological oxygen tension in tissue culture.

Authors:  Lakshmanan Jagannathan; Suresh Cuddapah; Max Costa
Journal:  Curr Pharmacol Rep       Date:  2016-01-23

6.  Comparison of the clinical application of reactive oxygen species and inflammatory markers in patients with endocarditis.

Authors:  Stanisław Ostrowski; Anna Marcinkiewicz; Dariusz Nowak; Radosław Zwoliński; Ryszard Jaszewski
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

7.  Tanshinone IIA and Cryptotanshinone Prevent Mitochondrial Dysfunction in Hypoxia-Induced H9c2 Cells: Association to Mitochondrial ROS, Intracellular Nitric Oxide, and Calcium Levels.

Authors:  Hyou-Ju Jin; Chun-Guang Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-04       Impact factor: 2.629

8.  Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species.

Authors:  Rajitha T Kolamunne; Irundika H K Dias; Ann B Vernallis; Melissa M Grant; Helen R Griffiths
Journal:  Redox Biol       Date:  2013-08-22       Impact factor: 11.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.